Found 8 matching trials
Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B PHASE2 Hepatitis B virus (HBV) causes a wide spectrum of liver diseases, such as f...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19 PHASE3 This study is a randomized, double-blind, multicenter, placebo-controlled t...
Show More Location
Hospital Interzonal General de Agudos Dr Jose Penna
Learn More & Join Trial
Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis PHASE2 Viral hepatitis C prognosis is related to the presence of a fibrosis and to...
Show More Location
Hopital du haut Leveque
Learn More & Join Trial
Novaferon in Non-hospitalized Adult Patients With Mild COVID-19 PHASE3 An Adaptive, Multicenter, Randomized, Double-blind, Placebo-Controlled Phas...
Show More Location
Tokyo Shinagawa Hospital
Learn More & Join Trial
Novaferon for COVID-19 Treatment Trial (NCTT-005) PHASE3 A multicenter, randomized, double-blind, placebo-controlled trial for hospi...
Show More Location
Chiba Aoba Municipal Hospital
Learn More & Join Trial
Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye NA The purpose of this study is to explore whether the drug pegylated-interfer...
Show More Location
Multiple Locations
Learn More & Join Trial
Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis PHASE3 The objective of this study is to compare the safety and efficacy of masiti...
Show More Location
UC Davis Health System , Department of Dermatology
Learn More & Join Trial
Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED) PHASE3 This study involves treatment with boceprevir or placebo in combination wit...
Show More Location
Multiple Locations
Learn More & Join Trial